|
Index of reports
> Cases with Condition Aggravated (28)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) where reactions include condition aggravated. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Risperdal Consta side effects in 31 year old male
Reported by a physician from Ireland on 2012-08-27
Patient: 31 year old male
Reactions: Condition Aggravated, Substance Abuse
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a physician from Ireland on 2012-08-21
Patient: male
Reactions: Condition Aggravated, Substance Abuse
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Possible Risperdal Consta side effects in 28 year old male
Reported by a physician from United States on 2012-07-06
Patient: 28 year old male
Reactions: Weight Increased, Incorrect Dose Administered, Blood Triglycerides Increased, Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizoaffective Disorder
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2012-06-08
Other drugs received by patient: Risperdal
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in 28 year old male
Reported by a physician from United States on 2012-06-26
Patient: 28 year old male
Reactions: Weight Increased, Incorrect Dose Administered, Blood Triglycerides Increased, Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2012-06-08
Risperdal Consta
Indication: Schizoaffective Disorder
Other drugs received by patient: Risperdal
Possible Risperdal Consta side effects in 43 year old male
Reported by a physician from United States on 2012-06-20
Patient: 43 year old male
Reactions: Psychomotor Hyperactivity, Persecutory Delusion, Hallucination, Auditory, Drug Level Increased, Drug Interaction, Condition Aggravated, Cognitive Disorder, Fear of Eating, Psychotic Disorder, Thought Blocking, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperidone
Dosage: 1 mg;bid;po 4 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder Bipolar Type
Risperdal Consta
Dosage: 37.5 mg;qow;im
Indication: Schizoaffective Disorder Bipolar Type
Terbinafine HCL
Indication: Nail Infection
Other drugs received by patient: Valproic Acid
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-23
Patient: female, weighing 70.8 kg (155.7 pounds)
Reactions: Agitation, Abasia, Urinary Tract Infection, Condition Aggravated, Eating Disorder, Aggression, Communication Disorder, Abnormal Loss of Weight, Hypertension, Clostridial Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Dementia
Risperdal Consta
Indication: Dementia Alzheimer's Type
Start date: 2012-04-01
End date: 2012-01-01
Risperdal
Administration route: Oral
Start date: 2011-01-01
End date: 2012-05-02
Risperdal
Administration route: Oral
Start date: 2011-01-01
End date: 2012-05-02
Risperdal Consta
Indication: Dementia
Start date: 2012-04-01
End date: 2012-01-01
Risperdal
Administration route: Oral
Indication: Dementia Alzheimer's Type
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in
Reported by a pharmacist from United States on 2012-03-14
Patient:
Reactions: Drug Ineffective, Condition Aggravated
Drug(s) suspected as cause:
Risperdal Consta
Invega Sustenna
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Possible Risperdal Consta side effects in 43 year old male
Reported by a physician from United States on 2012-03-14
Patient: 43 year old male
Reactions: Persecutory Delusion, Psychomotor Hyperactivity, Antipsychotic Drug Level Increased, Hallucination, Auditory, Condition Aggravated, Drug Interaction, Cognitive Disorder, Nail Infection, Fear of Eating, Psychotic Disorder, Hypophagia, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Terbinafine HCL
Indication: Nail Infection
Risperidone
Dosage: 1 mg;bid;po ; 4 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder Bipolar Type
Risperdal Consta
Dosage: 37.5 mg;qow;im
Indication: Schizoaffective Disorder Bipolar Type
Other drugs received by patient: Clonazepam; Valproic Acid; Bupropion HCL
Possible Risperdal Consta side effects in 43 year old male
Reported by a individual with unspecified qualification from United States on 2012-03-12
Patient: 43 year old male
Reactions: Agitation, Psychomotor Hyperactivity, Hallucination, Auditory, Condition Aggravated, Drug Interaction, Cognitive Disorder, Fear of Eating, Thought Blocking, Psychiatric Symptom
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bupropion HCL
Dosage: 150 mg, 1 in 1 d
Indication: Schizoaffective Disorder
Clonazepam
Dosage: 0.5 mg, 1 in 1 d
Indication: Schizoaffective Disorder
Risperdal Consta
Dosage: 37.5 mg, 1 in 2 wk, intramuscular since 4 years - ongoing
Lamisil
Indication: Nail Infection
Valproic Acid
Indication: Schizoaffective Disorder
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-03-05
Patient: male
Reactions: Confusional State, Vomiting, Pneumonia, Condition Aggravated, Gait Disturbance, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-21
Patient: female
Reactions: Inappropriate Schedule of Drug Administration, Condition Aggravated, Periorbital Haematoma, Loss of Consciousness
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Lithium Carbonate
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-02-14
Patient: male
Reactions: Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-02-02
Patient: male
Reactions: Psychotic Disorder, Hypothyroidism, Condition Aggravated, Gastrooesophageal Reflux Disease, Feeling Abnormal, Ulcer, Infectious Mononucleosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2011-10-29
End date: 2011-12-09
Abilify
Indication: Bipolar Disorder
Risperidone
Administration route: Oral
Indication: Bipolar Disorder
Invega Sustenna
Indication: Bipolar Disorder
Start date: 2012-01-01
End date: 2012-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2011-08-01
Other drugs received by patient: Celexa; Equetro; Trileptal
Possible Risperdal Consta side effects in 48 year old male
Reported by a physician from Mexico on 2011-12-23
Patient: 48 year old male, weighing 132.0 kg (290.4 pounds)
Reactions: Pneumonia, Psychomotor Hyperactivity, Condition Aggravated, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Clonazepam; Amphetamines
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23
Patient: male
Reactions: Condition Aggravated, Brain Neoplasm
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-08
Patient: female
Reactions: Product Quality Issue, Road Traffic Accident, Adverse Event, Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
End date: 2011-01-01
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-01
End date: 2011-01-01
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from France on 2011-10-21
Patient: female
Reactions: Condition Aggravated, Ill-Defined Disorder, Weight Increased, Incoherent, Hospitalisation, Suicide Attempt, Nervous System Disorder, Mental Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Loxapine HCL; Abilify; Clopixol
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United Kingdom on 2011-10-19
Patient: male
Reactions: Muscle Atrophy, Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from France on 2011-10-03
Patient: female
Reactions: Condition Aggravated, Ill-Defined Disorder, Weight Increased, Incoherent, Hospitalisation, Suicide Attempt, Mental Disorder, Nervous System Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Abilify; Clopixol; Loxapine HCL
|
